Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation (now known as Cencora, Inc.) on July 3, 2007. The report addresses a temporary suspension of trading under the company's employee benefit plans and trading restrictions for directors and executive officers.
Key Event: Planned Spin-Off
The filing relates to the planned spin-off of PharMerica Long-Term Care pursuant to an agreement with Kindred Healthcare, Inc. to combine their institutional pharmacy businesses into a separate public company (the "Transaction"). The expected closing date for this transaction was updated to July 31, 2007.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and employee benefit plan administration rather than financial performance.
Material Changes
- Transaction Timeline: The expected closing date for the PharMerica spin-off was revised to July 31, 2007.
- Plan Changes: Updates were made to the AmerisourceBergen Corporation Employee Investment Plan and the PharMerica, Inc. 401(k) Profit Sharing Plan to accommodate the transaction.
Guidance, Outlook, and Restrictions
Blackout Period
A "Blackout Period" was announced during which participants could not direct or diversify assets in the AmerisourceBergen Corporation Stock Fund or the PharMerica Stock Fund, nor obtain loans or distributions.
- Expected Start: Week of July 23, 2007.
- Expected End: Week of August 6, 2007.
- Duration: Not expected to last longer than 5 business days.
Trading Restrictions for Directors and Officers
Pursuant to Section 306(a) of the Sarbanes-Oxley Act of 2002 and SEC Regulation BTR, directors and executive officers were prohibited from purchasing, selling, or transferring shares of the Registrant's common stock (including derivatives) during the Blackout Period.
Investor Verification Checklist
- Confirm the actual start and end dates of the Blackout Period, as the filing only provides expected weeks.
- Verify the final closing date of the PharMerica/Kindred Healthcare transaction (originally expected July 31, 2007).
- Review subsequent filings for any extensions to the trading restrictions or changes to the spin-off structure.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.